Investors Should Watch Clorox Stock (CLX) Amid Dividend News
Analyzing Clorox’s Performance in the Fourth Fiscal Quarter
Clorox (CLX) reported net sales of $1.7 billion, which fell short of analysts’ expectation. However, the net sales increased 2.7% YoY.
Procter & Gamble Beats Third-Quarter Estimates
Procter & Gamble (PG) posted stronger-than-expected third-quarter results on Tuesday, April 23.
Colgate-Palmolive’s Developed Markets Remained a Drag in 1Q17
Net sales in North America fell 5.0% in 1Q17, reflecting a strong decline in volumes coupled with lower pricing.
Clorox’s Fiscal 2Q17 Sales Rose on Impressive Volumes
Clorox (CLX) delivered sales of $1.4 billion in fiscal 2Q17. The sales were in line with the consensus Wall Street analysts’ sales estimates.
Will Colgate-Palmolive Sustain Sales Momentum in 1Q18?
Analysts expect Colgate-Palmolive (CL) to report sales of $4.0 billion in 1Q18, which represents a YoY (year-over-year) rise of 6.6%.
Clorox’s Fiscal 2Q16 Revenue Is Estimated to Be $1.3 Billion
For fiscal 2Q16, Wall Street analysts’ consensus revenue estimate for Clorox is ~$1.3 billion, a 3.4% rise from the same quarter last year.
Why Analysts Expect Clorox’s Earnings to Fall in Fiscal 2Q18
Analysts expect Clorox to report adjusted earnings of $1.23 per share, a YoY (year-over-year) decline of 1.6%.
Why SunTrust Upgraded Colgate-Palmolive Stock
On October 11, 2017, SunTrust Robinson Humphrey upgraded Colgate-Palmolive (CL) stock to a “buy” from “hold” and increased the target price.
Will Procter & Gamble’s Sales Improve in Fiscal 2017?
After generating lower sales for 11 consecutive quarters, Procter & Gamble (PG) managed to report flat sales growth in fiscal 1Q17.
How Much Has Colgate-Palmolive Increased Its Dividend?
Colgate-Palmolive (CL) has a market capitalization of $60.9 billion. CL rose by 0.37% to close at $68.23 per share as of March 10, 2016.
Analysts Remain Neutral on Clorox Stock before 4Q17 Results
Analysts covering Clorox (CLX) have rated the stock a 2.9 on a scale of one (strong buy) to five (strong sell) and maintain a neutral outlook.
Will Cost Pressures Hurt KMB’s Q2 2018 EPS Growth Rate?
Analysts expect Kimberly-Clark (KMB) to report adjusted EPS of $1.57 in the second quarter.
Procter & Gamble’s Margins Could Remain Muted
Procter & Gamble’s management remains upbeat and expects productivity savings to drive its margins higher in coming quarters.
What’s behind Clorox’s Fiscal 3Q17 Earnings Beat?
The Clorox Company (CLX) reported its fiscal 3Q17 results on May 3, 2017. Its EPS (earnings per share) of $1.31 exceeded analysts’ consensus estimate of $1.30.
How Do Analysts Rate Clorox and Its Peers?
Of the 17 analysts covering Clorox Company (CLX), two analysts have rated the stock as a “buy” as of November 2.
Deutsche Bank Downgrades Church & Dwight Company to ‘Hold’
Church & Dwight (CHD) reported 3Q16 net sales of $870.7 million, a rise of 1.0% compared to net sales of $861.8 million in 3Q15.
How PG’s Valuation Compares to Peers
As of April 18, Procter & Gamble (PG) was trading at a 12-month forward PE (price-to-earnings) ratio of 22.8x.
How PG’s Valuation Looks Now
As of March 8, PG was trading at a 12-month forward PE ratio of 22.7x. The company is now trading at a higher valuation multiple than the S&P 500 Index.
Edgewell Increases Its Portfolio with a New Acquisition
Edgewell Personal Care Company (EPC) fell 2.8% to close at $73.87 per share during the first week of November 2016.
Procter & Gamble: Can Focus on 10 Product Categories Help 3Q16?
Procter & Gamble (PG) is set to release its fiscal 3Q16 earnings before the Markets open on April 26, 2016. In fiscal 2Q16, P&G missed revenue estimates for the fifth consecutive quarter.
How Is Clorox Improving Product Distribution?
For distribution in the United States, Clorox (CLX) sells or markets its products primarily through mass retail outlets, e-commerce channels, wholesale distributors, and medical supply distributors.
Mega Brands Set to Dominate in P&G’s New Product Portfolio
P&G plans to focus on superior brands in the 10 product categories in its portfolio. It expects one-third of them to surpass $1 billion in annual sales.
Why Did Clorox China Recall Some of Its Products?
The Clorox Company (CLX) has a market cap of $15.0 billion. It fell 0.67% and closed at $115.48 per share on November 23, 2016.
Will Sales and Cost Headwinds Stall the Recovery in KMB Stock?
Shares of Kimberly-Clark (KMB) have increased 8.5% since the company reported better-than-expected third-quarter results on October 22.
How Does Colgate-Palmolive’s Valuation Compare?
12-month forward price-to-earnings multiple As of January 17, Colgate-Palmolive (CL) was trading at a 12-month forward PE (price-to-earnings) multiple of 22.2x. The company is currently trading at a higher valuation multiple than the S&P 500, which has a forward PE of 17.6x, and the S&P 500 Consumer Staples, which has a forward PE of 20.3x. […]
What Could Stall the Recovery in Kimberly-Clark Stock?
Kimberly-Clark (KMB) stock has recovered nearly 6% in the last two trading days.
What’s behind Procter & Gamble’s Improving Dividend Trend?
Procter & Gamble recently announced a 4% hike in its quarterly dividend to $0.72 per share.
Barclays Upgraded Clorox to ‘Equal-Weight’
On January 9, 2017, Barclays upgraded Clorox’s rating to “equal-weight” from “underweight.” It set the stock’s price target at $111.0 from $115.0 per share.
Can Procter & Gamble’s Stock Price Gain Momentum?
Procter & Gamble’s stock has consistently fallen since the beginning of 2015. However, the stock was able to sustain some gains until September.
Why Clorox’s Top Line Could Continue to Impress in 2018
Clorox (CLX) registered healthy volumes growth in the United States (SPY) in 2017, which differentiates it from its peers.
Why Kimberly-Clark’s Gross Margins Fell Significantly in 1Q18
Kimberly-Clark’s adjusted operating margin fell 140 basis points to 17.4%, reflecting a lower gross margin.
Clorox Disappoints on Outlook
Clorox (CLX) continued its strong top-line and bottom-line performances in fiscal 1Q18.
Why Kimberly-Clark’s EPS Could Decline in Q1 2019
Analysts expect Kimberly-Clark to post adjusted earnings of $1.54 per share in the first quarter of 2019, which implies a YoY decline of 9.9%.
What’s Behind Clorox’s Industry-Leading Sales Growth?
The Clorox Company (CLX) has managed to generate industry-leading sales despite challenges.
Procter & Gamble Stock: Analysts’ Ratings Trend
Of the 23 analysts covering Procter & Gamble stock, 74.0% recommend a “hold,” 22.0% recommend a “buy,” and 4.0% recommend a “sell.”
Here’s What Drove Kimberly-Clark’s Margins in 1Q17
Kimberly-Clark (KMB) generated about $110.0 million in cost savings in 1Q17 and remains on track to save about $400.0 million in 2017.
Will the Rally in Clorox Stock Continue?
The COVID-19 pandemic boosted Clorox’s (NYSE:CLX) sales. People started paying more attention to cleaning and sanitizing.
Is Clorox a ‘Buy’ after Its Stellar Q3 Results?
Clorox (NYSE:CLX) raised its outlook for 2020 after the company generated strong sales in the third quarter of fiscal 2020.
Why Investors Expect Clorox to Deliver Strong Q1 Results
Increased hygiene requirements amid COVID-19 caused a major rise in demand for Clorox’s tissues, disinfectants, and other cleaning products.
Procter & Gamble Delivers Mixed Q3 Results amid COVID-19
Today, Procter & Gamble (NYSE:PG) announced better-than-expected earnings for the third quarter of fiscal 2020. The fiscal third quarter ended on March 31.
Kraft Heinz Predicts Strong Q1 Sales Due to Pandemic-Led Demand
Kraft Heinz (NASDAQ:KHC) stock rose 2.7% on April 7. The company provided an upbeat business update for its first quarter.
Costco Stock Looks Attractive amid COVID-19 Pandemic
Costco (NASDAQ:COST), like Walmart (NYSE:WMT) and Target (NYSE:TGT), is one of the companies that’s benefiting amid the coronavirus pandemic.
Why Walgreens Stock Fell despite Upbeat Q2 Earnings
Walgreens Boots Alliance (NASDAQ:WBA) reported strong earnings for the second quarter of fiscal 2020. The second quarter ended on February 29.
Jefferies Upgraded Procter & Gamble and Kimberly Clark
Jefferies is bullish about consumer staples giants Procter & Gamble (NYSE:PG) and Kimberly Clark (NYSE:KMB). The firm upgraded both of the stocks.
Should You Buy Ulta Beauty Stock? Citigroup Thinks So
Ulta Beauty (NASDAQ:ULTA) stock rose 0.7% on March 20. Citigroup analyst Kelly Cargo is optimistic about the company’s long-term earnings power.
Is Procter & Gamble a Good Bet for Investors?
The defensive nature of Procter & Gamble stock and its strong dividends make it a good buy in a challenging market environment.
Analysts Upgrade Walmart amid Stock Market Turmoil
Analysts are optimistic about Walmart (NYSE:WMT) even though the US stock market crashed due to the coronavirus outbreak.
Clorox Gets Rating Upgrade, Coronavirus Triggers Demand
Clorox stock rose 4.1% on March 16, even though the US stock market crashed amid the coronavirus pandemic. JPMorgan Chase upgraded its rating.
Procter & Gamble Stock: What’s Fueling the Growth?
Procter & Gamble stock has generated a significant amount of wealth for investors this year. The company boosted shareholders’ returns.
Kimberly-Clark and Clorox: Barclays Is Bullish and Bearish
On September 23, Barclays analyst Lauren Lieberman upgraded Kimberly-Clark (KMB) stock and downgraded the Clorox Company (CLX) stock.
Newell Brands Stock Rose after Higher Revenue Outlook
On August 2, Newell Brands (NWL) stock rose 14.2%. The company beat analysts’ expectations for its second-quarter results.
Clorox Posts Mixed Q4 Results, Weakness to Persist
On Thursday, Clorox posted mixed fourth-quarter results. Clorox reported net revenues of $1.63 billion, which fell short of analysts’ estimate.
Why Clorox Stock Is Underperforming Peers
Clorox stock (CLX) is down about 8% since the company posted its third quarter of fiscal 2019 earnings on May 1.
Q1 Beat and Improved Outlook Could Boost Church & Dwight Stock
Church & Dwight (CHD) has impressed with its better-than-expected first-quarter results and margin expansion.
Currency and Competition Hurt Clorox’s Q3 Sales
Clorox (CLX) posted net sales of $1.55 billion, which fell short of Wall Street’s estimate of $1.57 billion.
Clorox Stock Drops 7.2% on Weak Quarterly Results
Clorox (CLX) stock fell 7.2% on May 1 following the company’s weaker-than-expected third-quarter results.
What’s on the Horizon for Colgate-Palmolive Stock?
Most of the analysts maintained a neutral stance on Colgate-Palmolive stock. Persistent challenges will likely limit the upside.
Procter & Gamble Posted Strong Sales in Q3
Procter & Gamble (PG) posted better-than-expected third-quarter sales. Procter & Gamble’s net sales of $16.5 billion beat analysts’ estimate.
What Drove Kimberly-Clark’s Q1 Earnings?
Kimberly-Clark (KMB) posted better-than-expected earnings in the first quarter of 2019.
Kimberly-Clark Stock Rose on Stronger-Than-Expected Q1 Results
Kimberly-Clark (KMB) stock rose 5.4% on April 22 after the company released stronger-than-expected first-quarter results.
Persisting Challenges Could Hurt Colgate-Palmolive in Q1
Colgate-Palmolive (CL) is scheduled to announce its first-quarter earnings results before the market opens on April 26.
What Analysts Suggest for PG Stock ahead of Its Q3 Results
The majority of analysts continue to suggest “holds” on Procter & Gamble (PG) stock.
What to Expect from Procter & Gamble’s Q3 2019 Results
Procter & Gamble (PG) is scheduled to announce its earnings results for the third quarter of fiscal 2019 before the market opens on April 23.
Is Kimberly-Clark Stock Heading for a Decline?
Kimberly-Clark (KMB) stock has increased 8.1% so far this year and trades at a forward PE multiple of 18.7x
Why Kimberly-Clark’s Sales Could Continue to Decline in Q1
Kimberly-Clark (KMB) has exceeded analysts’ sales estimate in the past two consecutive quarters.
Why Analysts Have a Bleak Outlook for Kimberly-Clark’s Q1
Kimberly-Clark (KMB) is expected to announce its first-quarter results before the markets open on Monday, April 22.
Where Clorox Stock Could Be Heading
Clorox stock is trading at a forward PE multiple of 24.1x, which looks unattractive given its projected growth rate of 6.3% for fiscal 2020.
Why JPMorgan Chase Has Downgraded Clorox Stock
The Clorox Company (CLX) stock fell ~1% on April 8 after JPMorgan Chase downgraded it to an “underweight” from a “neutral.”
Why Wells Fargo Upgraded Procter & Gamble Stock
Wells Fargo upgraded its rating on Procter & Gamble stock to “outperform” from “market perform” and raised its target price to $115 from $91 per share.
Church & Dwight Announces Acquisition, Stock Rises ~4%
On March 28, Church & Dwight (CHD) announced that it has agreed to acquire the FLAWLESS brand from Ideavillage for ~$900 million.
What’s Ahead For KMB and CL Stock?
Kimberly-Clark (KMB) and Colgate-Palmolive (CL) have been strong this year, driven by improved organic sales due to higher pricing.
Why Analysts Remain on Sidelines for CHD and CLX
The majority of analysts covering Church & Dwight (CHD) and Clorox (CLX) stock maintain a neutral outlook.
What’s Ahead for Church & Dwight and Clorox?
Church & Dwight (CHD) and Clorox (CLX) have underperformed peers so far this year.
What Analysts Recommend for PG, CL, CLX, KMB, and CHD Stock
Most analysts recommend “hold” for consumer packaged goods stocks.
What’s Ahead for PG, KMB, CL, CLX, and CHD Stock?
Most CPG (consumer packaged goods) manufacturers’ results impressed in the recent quarter, especially their sales.
Will Procter & Gamble Sustain Momentum in the Second Half?
Procter & Gamble (PG) has impressed with its financial performance in the first half of fiscal 2019 thanks to improved underlying sales.
Why the Uptrend in Colgate-Palmolive Stock Might Not Hold
Colgate-Palmolive stock has generated better returns than most of its peers so far this year and has outperformed the broader market.
What Drove Clorox’s Q2 Sales?
Clorox (CLX) posted net sales of $1.47 billion during the second quarter.
Will Ongoing Challenges Limit the Upside in CL Stock?
Colgate-Palmolive (CL) reported better-than-expected fourth-quarter results on Friday, January 25.
Procter & Gamble Posted Strong Q2 Results, Stock Rose ~5%
On January 23, Procter & Gamble (PG) shares closed at 4.9%. The company posted impressive results for the second quarter of fiscal 2019.
Kimberly-Clark’s Earnings Miss Dragged Stock Down
Kimberly-Clark (KMB) posted mixed fourth-quarter results on January 23.
IFF’s Frutarom Completes Acquisition of 60% in Thailand’s Mighty
On January 18, International Flavors and Fragrances (IFF) announced that Frutarom acquired 60% of Mighty.
Will Colgate-Palmolive’s Q4 Results Stall the Recovery in Its Stock?
Colgate-Palmolive (CL) is expected to announce its fourth-quarter earnings results on January 25.
Procter & Gamble’s Valuation Compared to Its Peers
Procter & Gamble (PG) stock trades at 20.8x its estimated fiscal 2019 EPS of $4.41, which doesn’t look attractive.
Procter & Gamble Stock: Analysts’ Recommendations
Most of the analysts maintained a neutral outlook on Procter & Gamble (PG) stock.
Why Kimberly-Clark’s Q4 Revenues Are Expected to Decline
Kimberly-Clark (KMB) could continue to disappoint investors with its tepid sales performance at least in the foreseeable future.
How KMB Stock Could Perform ahead of Q4 Results
Kimberly-Clark (KMB) is scheduled to announce its fourth-quarter results on Wednesday, January 23.
Will Procter & Gamble’s Q2 Results Pressure Its Stock?
On January 23, Procter & Gamble (PG) is expected to announce its results for the second quarter of fiscal 2019.
IFF Collaborates with Aryballe on Digital Nose
On January 7, International Flavors and Fragrances (IFF) announced that it has entered into a collaboration with Aryballe.
Investing Defensively Can Lose You a Fortune
I bet you may have heard a lot about investing defensively while the market faded.
Why IFF’s Short Interest Is on a Declining Trend
The latest short interest report indicates that International Flavors & Fragrances’ short interest has been on a declining trend since rising to 4.8%.
IFF’s Dividend Yield Is at Its Highest—Is This Encouraging?
On December 24, International Flavors & Fragrances’ dividend yield was 2.27%, its highest quarterly dividend yield since the first quarter of 2013.
Looking at IFF’s Free Cash Flow Trend
In this article, we’ll discuss IFF’s free cash flow trend to see whether its free cash flow can sustain its robust dividend growth plans.
IFF-Lucas Meyer Cosmetics Acquires Sustainable Ingredients
IFF-Lucas Meyer Cosmetics acquired three personal care ingredients and intellectual property rights from Kemin Industries.
Five Consumer Staples Stocks to Be Thankful For—Even This Year
So far, 2018 has been a difficult year for the consumer staples industry—even tougher than last year.
IFF’s Q3 Adjusted Earnings Met Analysts’ Expectations
On November 5, International Flavors and Fragrances (IFF) reported its third-quarter earnings after the market closed.
Procter & Gamble: Analysts’ Recommendations before Q1 2019
Of the 24 analysts tracking PG stock, 17 analysts recommend a “hold” rating, six analysts suggest a “buy,” and one analyst recommends a “sell.”
What Analysts Forecast for P&G’s Bottom Line in Q1 2019
Procter & Gamble has exceeded analysts’ earnings estimates in the past 13 consecutive quarters, with an average earnings surprise of 4.4%.
IFF Gained 6.8% in September: Can It Maintain Its Momentum?
Although IFF’s 100-day moving average has fallen from $150.00 to its current level, it’s showing signs of stabilization.